These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 21840181)

  • 1. Mechanisms of in-vitro-selected daptomycin-non-susceptibility in Staphylococcus aureus.
    Patel D; Husain M; Vidaillac C; Steed ME; Rybak MJ; Seo SM; Kaatz GW
    Int J Antimicrob Agents; 2011 Nov; 38(5):442-6. PubMed ID: 21840181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to daptomycin and vancomycin in an in vitro dynamic model.
    Firsov AA; Smirnova MV; Lubenko IY; Vostrov SN; Portnoy YA; Zinner SH
    J Antimicrob Chemother; 2006 Dec; 58(6):1185-92. PubMed ID: 17028094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic and genotypic correlates of daptomycin-resistant methicillin-susceptible Staphylococcus aureus clinical isolates.
    Kang KM; Mishra NN; Park KT; Lee GY; Park YH; Bayer AS; Yang SJ
    J Microbiol; 2017 Feb; 55(2):153-159. PubMed ID: 28120188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial daptomycin selection generates daptomycin-nonsusceptible Staphylococcus aureus strains with a heterogeneous vancomycin-intermediate phenotype.
    Camargo IL; Neoh HM; Cui L; Hiramatsu K
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4289-99. PubMed ID: 18824611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daptomycin nonsusceptibility in Staphylococcus aureus with reduced vancomycin susceptibility is independent of alterations in MprF.
    Pillai SK; Gold HS; Sakoulas G; Wennersten C; Moellering RC; Eliopoulos GM
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2223-5. PubMed ID: 17404001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. dltA overexpression: A strain-independent keystone of daptomycin resistance in methicillin-resistant Staphylococcus aureus.
    Cafiso V; Bertuccio T; Purrello S; Campanile F; Mammina C; Sartor A; Raglio A; Stefani S
    Int J Antimicrob Agents; 2014 Jan; 43(1):26-31. PubMed ID: 24183798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged Exposure to β-Lactam Antibiotics Reestablishes Susceptibility of Daptomycin-Nonsusceptible Staphylococcus aureus to Daptomycin.
    Jenson RE; Baines SL; Howden BP; Mishra NN; Farah S; Lew C; Berti AD; Shukla SK; Bayer AS; Rose WE
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32601160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of compensatory mutations associated with restoration of daptomycin-susceptibility in daptomycin non-susceptible methicillin-resistant Staphylococcus aureus and the role mprF mutations.
    Kanesaka I; Fujisaki S; Aiba Y; Watanabe S; Mikawa T; Katsuse AK; Takahashi H; Cui L; Kobayashi I
    J Infect Chemother; 2019 Jan; 25(1):1-5. PubMed ID: 30322736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of daptomycin resistance on Staphylococcus aureus virulence.
    Cameron DR; Mortin LI; Rubio A; Mylonakis E; Moellering RC; Eliopoulos GM; Peleg AY
    Virulence; 2015; 6(2):127-31. PubMed ID: 25830650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus strain in a patient with endocarditis.
    Julian K; Kosowska-Shick K; Whitener C; Roos M; Labischinski H; Rubio A; Parent L; Ednie L; Koeth L; Bogdanovich T; Appelbaum PC
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3445-8. PubMed ID: 17620372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a vancomycin-intermediate Staphylococcus aureus (VISA) strain by two amino acid exchanges in VraS.
    Berscheid A; François P; Strittmatter A; Gottschalk G; Schrenzel J; Sass P; Bierbaum G
    J Antimicrob Chemother; 2014 Dec; 69(12):3190-8. PubMed ID: 25103491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of the two-component system and cell-wall biosynthesis-related genes was associated with the reversion to daptomycin susceptibility in daptomycin non-susceptible methicillin-resistant Staphylococcus aureus.
    Iwata Y; Satou K; Tsuzuku H; Furuichi K; Senda Y; Sakai-Takemori Y; Wada T; Fujita S; Miyake T; Yasuda H; Sakai N; Kitajima S; Toyama T; Shinozaki Y; Sagara A; Miyagawa T; Hara A; Shimizu M; Kamikawa Y; Kaneko S; Wada T
    Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1839-1845. PubMed ID: 28477235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LC-MS/MS characterization of phospholipid content in daptomycin-susceptible and -resistant isolates of Staphylococcus aureus with mutations in mprF.
    Rubio A; Moore J; Varoglu M; Conrad M; Chu M; Shaw W; Silverman JA
    Mol Membr Biol; 2012 Feb; 29(1):1-8. PubMed ID: 22276671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin/clavulanic acid or ampicillin.
    Entenza JM; Giddey M; Vouillamoz J; Moreillon P
    Int J Antimicrob Agents; 2010 May; 35(5):451-6. PubMed ID: 20185277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of mprF mutations with cross-resistance to daptomycin and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA).
    Thitiananpakorn K; Aiba Y; Tan XE; Watanabe S; Kiga K; Sato'o Y; Boonsiri T; Li FY; Sasahara T; Taki Y; Azam AH; Zhang Y; Cui L
    Sci Rep; 2020 Sep; 10(1):16107. PubMed ID: 32999359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of daptomycin resistance in Staphylococcus aureus.
    Kaatz GW; Lundstrom TS; Seo SM
    Int J Antimicrob Agents; 2006 Oct; 28(4):280-7. PubMed ID: 16963232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gain-of-Function Mutations in the Phospholipid Flippase MprF Confer Specific Daptomycin Resistance.
    Ernst CM; Slavetinsky CJ; Kuhn S; Hauser JN; Nega M; Mishra NN; Gekeler C; Bayer AS; Peschel A
    mBio; 2018 Dec; 9(6):. PubMed ID: 30563904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of genetic changes associated with daptomycin nonsusceptibility in Staphylococcus aureus.
    Ma Z; Lasek-Nesselquist E; Lu J; Schneider R; Shah R; Oliva G; Pata J; McDonough K; Pai MP; Rose WE; Sakoulas G; Malik M
    PLoS One; 2018; 13(6):e0198366. PubMed ID: 29879195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
    Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
    Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of daptomycin resistance in daptomycin-naïve rabbits with methicillin-resistant Staphylococcus aureus prosthetic joint infection is associated with resistance to host defense cationic peptides and mprF polymorphisms.
    Mishra NN; Yang SJ; Chen L; Muller C; Saleh-Mghir A; Kuhn S; Peschel A; Yeaman MR; Nast CC; Kreiswirth BN; Crémieux AC; Bayer AS
    PLoS One; 2013; 8(8):e71151. PubMed ID: 23990934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.